{name}
{subtitle}
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~14 mi. (Rionero in Vulture, Italy, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~14 mi. (Rionero in Vulture, Italy, +156 more cities)
facility
Irccs-Crob /Id# 170955
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations
city
~14 mi. (Rionero in Vulture, Italy, +120 more cities)
facility
IRCCS Centro di Riferimento Oncologico di Basilicata
biomarker
FGFR3 A391E, +9 more biomarkers
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~66 mi. (Torrette, Italy, +158 more cities)
facility
Azienda Ospedaliera Umberto I- Torrette ( Site 1009)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
city
~75 mi. (Avellino, Italy, +115 more cities)
facility
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati
biomarker
ERBB2 Amplification, +7 more biomarkers
drug type
immunotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~75 mi. (Bari, Italy, +92 more cities)
facility
IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 0193)
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~75 mi. (Avellino, Italy, +151 more cities)
facility
GSK Investigational Site
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
city
~75 mi. (Bari, Italy, +41 more cities)
facility
A.O. U. Consorziale Policlinico di Bari; Oncologia Ginecologica
condition
Fallopian Tube Carcinoma, +2 more conditions
drug
ado-trastuzumab emtansine, +5 more drugs
drug type
chemotherapy, +2 more types